Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil

• Published in: Oncology reports Vol. 12; no. 1; p. 187
• Main Authors: Haveman, J, Castro Kreder, N, Rodermond, H M, van Bree, C, Franken, N A P, Stalpers, L J A, Zdzienicka, M Z, Peters, G J
• Format: Journal Article
• Language: English
• Published: Greece 01-07-2004
• Subjects: Animals; Antimetabolites, Antineoplastic - toxicity; Cell Division - drug effects; Cell Division - radiation effects; Cell Line; CHO Cells; Cisplatin - toxicity; Cricetinae; Deoxycytidine - analogs & derivatives; Deoxycytidine - toxicity; DNA - genetics; DNA Repair - drug effects; DNA Repair - radiation effects; Dose-Response Relationship, Drug; Fluorouracil - toxicity; X-Rays
• DOI: 10.3892/or.12.1.187
• ISSN: 1021-335X

Five mutant Chinese hamster cell lines deficient in DNA repair with the corresponding parental cell lines were used to determine their sensitivity to cisplatin, 5-fluorouracil and gemcitabine. The mutations in the cell lines led to defective single strand break repair (EM-C11), defective recombination mediated repair (irs1SF), defective double strand break repair (XR-V15B, a Ku-80 mutant and CR-C1, a DNA-PKcs mutant) and an AT-like mutation (VC-4). All mutant cell lines had an impaired doubling time during exponential growth and an increased sensitivity to X-irradiation. We may conclude that for cisplatin-induced cytotoxicity the homologous recombination-associated DNA repair plays an important role in the repair of the cisplatin induced lesions, confirming previous results. In 5-FU and gemcitabine induced toxicity to cells, repair processes involved with radiation-induced damage were not implicated. This is in striking contrast to the role of cisplatin in radiosensitization where inhibition of the NHEJ pathway is implicated, and to the role of gemcitabine in sensitization where specific interference with the HR pathway is implicated.